Path analysis diagram illustrating the associations between alexithymia, social support, anticipated stigma and patient satisfaction, with their respective correlation coefficients... حسب Keya Bibikar (22386306)

Soil partice-size distribution. حسب Yonggang Huang (223155)

"…When the length of UHMWPE is greater than 9 mm, there is no significant decrease in the free swelling ratio of the reinforced soil (<i>p</i> = 0.165). …"

Variation of the most appropriate p value significance threshold with different ratios of the standard deviations and sample sizes. حسب Farrokh Habibzadeh (12256529)

الموضوعات:

Blocking SLAMF5 significantly delayed the onset of the disease and reduced its severity. حسب Laura Bellassen (22209109)

Change in Watt’s Connectedness Scale, Subscales by Treatment Group. حسب Benjamin R. Lewis (22279166)

الموضوعات:

Primary and secondary efficacy end points (intention-to-treat population). حسب Benjamin R. Lewis (22279166)

الموضوعات:

Demographic and clinical characteristics of participants at baseline. حسب Benjamin R. Lewis (22279166)

الموضوعات:

Study-related adverse events. حسب Benjamin R. Lewis (22279166)

الموضوعات:

Study flow chart. حسب Benjamin R. Lewis (22279166)

الموضوعات:

Change in QIDS-SR-16 and MBI-HSS-MP by Treatment Group. حسب Benjamin R. Lewis (22279166)

الموضوعات:

Study CONSORT diagram. حسب Benjamin R. Lewis (22279166)

الموضوعات:

Change in Demoralization Scale (DSII) by Treatment Group. حسب Benjamin R. Lewis (22279166)

الموضوعات:

Change in Watt’s Connectedness Scale (WCS), General Connectedness by Treatment Group. حسب Benjamin R. Lewis (22279166)

الموضوعات:

Arctigenin decreased proliferation in colorectal cancer cells with no significant effect on normal cells. حسب Xiang-Fan Chen (13932983)

RTA408 significantly reduces RGCs loss. حسب Hongmei Qian (538647)

الموضوعات:

Ami-NPs significantly reduce immobility compared to Ami-S. حسب Ramón Eduardo Valadez-Lemus (20805371)

الموضوعات:

Schematic diagram of experimental injector size. حسب Lei Bai (631944)

الموضوعات:

Voxel-based whole-brain analysis shows regional and dose-dependent effects of netoglitazone in decreasing plaque mean size. حسب Francesca Catto (21253435)

"…However, there is only a minimal effect on decreasing plaque size. (C) Short-term-treatment with a high dose of netoglitazone reveals a significant reduction in plaque size, especially observed in the hippocampus, striatum, thalamus, hypothalamus, midbrain, and hindbrain. …"

RTA408 significantly reduces RGCs loss in glaucoma. حسب Hongmei Qian (538647)

الموضوعات:

PBM significantly reduces hyperphosphorylation of tau with no effect on total tau expression. حسب Kevin J. Johnson (2647639)